ATE161424T1 - Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält - Google Patents

Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält

Info

Publication number
ATE161424T1
ATE161424T1 AT95921029T AT95921029T ATE161424T1 AT E161424 T1 ATE161424 T1 AT E161424T1 AT 95921029 T AT95921029 T AT 95921029T AT 95921029 T AT95921029 T AT 95921029T AT E161424 T1 ATE161424 T1 AT E161424T1
Authority
AT
Austria
Prior art keywords
substances
casein
pct
dialysis fluid
bicarbonations
Prior art date
Application number
AT95921029T
Other languages
English (en)
Inventor
Thomas Gilchrist
William Manson
Original Assignee
Giltech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giltech Ltd filed Critical Giltech Ltd
Application granted granted Critical
Publication of ATE161424T1 publication Critical patent/ATE161424T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95921029T 1994-06-02 1995-06-02 Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält ATE161424T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9411009A GB9411009D0 (en) 1994-06-02 1994-06-02 Dialysis fluid

Publications (1)

Publication Number Publication Date
ATE161424T1 true ATE161424T1 (de) 1998-01-15

Family

ID=10756046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95921029T ATE161424T1 (de) 1994-06-02 1995-06-02 Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält

Country Status (11)

Country Link
US (1) US5780438A (de)
EP (1) EP0731711B1 (de)
JP (1) JPH10505322A (de)
CN (1) CN1153588C (de)
AT (1) ATE161424T1 (de)
AU (1) AU682609B2 (de)
CA (1) CA2191769C (de)
DE (1) DE69501314T2 (de)
ES (1) ES2114322T3 (de)
GB (1) GB9411009D0 (de)
WO (1) WO1995033477A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0958832B1 (de) 1998-05-21 2006-01-25 Nipro Corporation Albumin enthaltende Lösung für die Peritonealdialyse
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6770148B1 (en) * 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
JP4205227B2 (ja) 1999-01-11 2009-01-07 カルピス株式会社 ペプチド含有液の精製方法
EP2052751A3 (de) * 1999-09-22 2009-06-03 Advanced Renal Technologies Anwendung eines Dialysats mit hohem Zitratgehalt
DE10114283C2 (de) * 2000-12-22 2003-04-24 Fresenius Medical Care De Gmbh Verfahren zur Ermittlung der Ionenkonzentration des Blutes eines Patienten bei der citrat-antikoagulierten Hämodialyse und/oder Hämofiltration; Dialysegerät
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US7053059B2 (en) 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
KR20150028116A (ko) * 2013-09-05 2015-03-13 삼성전자주식회사 아미노산계 이온성 올리고머를 포함한 유도 용질

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
DE3683583D1 (de) * 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis

Also Published As

Publication number Publication date
DE69501314D1 (de) 1998-02-05
MX9606042A (es) 1998-06-30
AU2623895A (en) 1996-01-04
WO1995033477A1 (en) 1995-12-14
JPH10505322A (ja) 1998-05-26
GB9411009D0 (en) 1994-07-20
ES2114322T3 (es) 1998-05-16
CA2191769A1 (en) 1995-12-14
EP0731711A1 (de) 1996-09-18
AU682609B2 (en) 1997-10-09
US5780438A (en) 1998-07-14
CN1153588C (zh) 2004-06-16
EP0731711B1 (de) 1997-12-29
CN1150759A (zh) 1997-05-28
CA2191769C (en) 2005-03-15
DE69501314T2 (de) 1998-07-23

Similar Documents

Publication Publication Date Title
ATE161424T1 (de) Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält
WO1995021601A3 (en) Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
KR950702248A (ko) 단백질을 기초로 한 전달 시스템(protein based delivery system)
HUP0302304A2 (hu) Tejeredetű csontvédő kompozíciók
DK0706378T3 (da) Ny farmaceutisk formulering.
NL970008I1 (nl) Derivaat van een weefselplasminogeenactivator.
ATE169304T1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
EP1484339A3 (de) Kallikreinhemmende "Kunitz-Domäne"Proteine dafür kodierende Nukleinsäure
BR9909472A (pt) Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
DE69309712D1 (de) Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum
NO954320L (no) Lyosfærer omfattende gonadotropin
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
FR2837098B1 (fr) Composition cosmetique ou pharmaceutique comprenant des peptides, procedes de traitement et utilisations
DK1539964T3 (da) Cellectin-komplementaktiverende proteinkimærer
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
DE69420145D1 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
DK0466833T3 (da) Insekticide og synergistiske miticide midler
DE60140493D1 (de) Verfahren zur Reinigung stark anionischer Proteine
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
ES2103482T3 (es) Antigeno de linfocitos t citotoxicos utilizado como inhibidor de la cisteina proteasa.
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
Critical Care Society of South Africa Working Group Severe sepsis and the role of novel therapeutic agents. Position statement of the Critical Care Society of South Africa on severe sepsis and the role of novel therapeutic agents such as drotrecogin alfa (activated)
UA9703A (uk) Антипротеіназний засіб

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee